Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety
- PMID: 7982867
- DOI: 10.1097/00004583-199410000-00012
Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety
Abstract
Objective: To determine whether there are differences in noradrenergic or adrenergic functioning in children with attention-deficit hyperactivity disorder (ADHD) with and without anxiety.
Method: ADHD children with and without a comorbid overanxious (ANX) disorder were compared to each other and to normal controls in terms of 2-hour urinary excretion of norepinephrine (NE), epinephrine (EPI), and their metabolites. All subjects performed a fixed series of mentally stressful tasks during the collection period.
Results: Children with ADHD, regardless of comorbid anxiety, excreted more normetanephrine (NMN), the chief extracellular metabolite of NE, than controls, as well as more vanillylmandelic acid. Children with ADHD alone had lower NE/NMN and EPI/metanephrine ratios compared to controls. Children with ADHD/ANX excreted more EPI than ADHD children without anxiety.
Conclusions: Children with ADHD may have a higher tonic activity of the noradrenergic system than controls, while children with comorbid ADHD/ANX may be differentiated from those with ADHD alone by higher adrenergic activity.
Similar articles
-
Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder.J Am Acad Child Adolesc Psychiatry. 1992 Mar;31(2):197-203. doi: 10.1097/00004583-199203000-00003. J Am Acad Child Adolesc Psychiatry. 1992. PMID: 1564019
-
Performance monitoring and response inhibition in anxiety disorders with and without comorbid ADHD.Depress Anxiety. 2007;24(4):227-32. doi: 10.1002/da.20237. Depress Anxiety. 2007. PMID: 17004236
-
Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting.Psychiatry Res. 2008 Jan 15;157(1-3):201-9. doi: 10.1016/j.psychres.2004.12.015. Epub 2007 Nov 19. Psychiatry Res. 2008. PMID: 18023880
-
Adrenomedullary function during cognitive testing in attention-deficit/hyperactivity disorder.J Am Acad Child Adolesc Psychiatry. 2000 May;39(5):635-43. doi: 10.1097/00004583-200005000-00018. J Am Acad Child Adolesc Psychiatry. 2000. PMID: 10802982 Review.
-
Catecholamines in attention-deficit hyperactivity disorder: current perspectives.J Am Acad Child Adolesc Psychiatry. 1996 Mar;35(3):264-72. doi: 10.1097/00004583-199603000-00006. J Am Acad Child Adolesc Psychiatry. 1996. PMID: 8714313 Review.
Cited by
-
Urinary neurotransmitter analysis and canine behavior assessment.Front Vet Sci. 2023 Feb 6;10:1124231. doi: 10.3389/fvets.2023.1124231. eCollection 2023. Front Vet Sci. 2023. PMID: 36814465 Free PMC article.
-
Attention-deficit/hyperactive disorder updates.Front Mol Neurosci. 2022 Sep 21;15:925049. doi: 10.3389/fnmol.2022.925049. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36211978 Free PMC article. Review.
-
Urinary Neurotransmitter Patterns Are Altered in Canine Epilepsy.Front Vet Sci. 2022 May 16;9:893013. doi: 10.3389/fvets.2022.893013. eCollection 2022. Front Vet Sci. 2022. PMID: 35651965 Free PMC article.
-
Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders.Metab Brain Dis. 2022 Jan;37(1):123-146. doi: 10.1007/s11011-021-00824-2. Epub 2021 Sep 3. Metab Brain Dis. 2022. PMID: 34476718 Review.
-
The association between obesity and hyperactivity/anxiety among elementary school students in Japan.Int J Behav Med. 2020 Feb;27(1):79-86. doi: 10.1007/s12529-019-09827-x. Int J Behav Med. 2020. PMID: 31820287
